-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EmGfrqnywCftdl3coiwdGXRKpLXjRKOiDEJMwjWUqivkQh0r9wlahnmZw0BPPNPA xcMJUlAZYdBbqElnWlterw== 0000716054-06-000026.txt : 20061128 0000716054-06-000026.hdr.sgml : 20061128 20061128145442 ACCESSION NUMBER: 0000716054-06-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061127 FILED AS OF DATE: 20061128 DATE AS OF CHANGE: 20061128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12943 FILM NUMBER: 061241998 BUSINESS ADDRESS: BUSINESS PHONE: 8584522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-11-27 0000716054 CYPRESS BIOSCIENCE INC CYPB 0001055666 KRANZLER JAY D 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121 1 1 0 0 CEO Common Stock 2006-11-27 4 S 0 100 8.05 D 203224 I By Trust Common Stock 2006-11-27 4 S 0 300 8.06 D 202924 I By Trust Common Stock 2006-11-27 4 S 0 400 8.07 D 202524 I By Trust Common Stock 2006-11-27 4 S 0 200 8.08 D 202324 I By Trust Common Stock 2006-11-27 4 S 0 200 8.09 D 202124 I By Trust Common Stock 2006-11-27 4 S 0 100 8.10 D 202024 I By Trust Common Stock 2006-11-27 4 S 0 800 8.11 D 201224 I By Trust Common Stock 2006-11-27 4 S 0 300 8.12 D 200924 I By Trust Common Stock 2006-11-27 4 S 0 300 8.13 D 200624 I By Trust Common Stock 2006-11-27 4 S 0 100 8.14 D 200524 I By Trust Common Stock 2006-11-27 4 S 0 400 8.15 D 200124 I By Trust Common Stock 2006-11-27 4 S 0 900 8.16 D 199224 I By Trust Common Stock 2006-11-27 4 S 0 500 8.17 D 198724 I By Trust Common Stock 2006-11-27 4 S 0 100 8.20 D 198624 I By Trust Common Stock 2006-11-27 4 S 0 100 8.22 D 198524 I By Trust Common Stock 2006-11-27 4 S 0 100 8.25 D 198424 I By Trust Common Stock 2006-11-27 4 S 0 100 8.27 D 198324 I By Trust Common Stock 625 D Common Stock 89570 I By 401(k) plan The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2006. /s/ Denise Wheeler Attorney-in-Fact 2006-11-28 -----END PRIVACY-ENHANCED MESSAGE-----